Peptide API subsidiary of Aurobindo Pharma with a plant near Hyderabad. Makes generic peptide APIs and runs GMP contract projects from mg to kg scale.
- Model
- CDMO
- Manufacturer?
- Yes
Vasopressin is a nine-amino-acid hormone used in vasodilatory shock (Vasostrict).
7 listed companies hold an active US Type II Drug Master File for Vasopressin API, based in India (4), Switzerland (2), Spain (1). 6 have a regulator record of GMP manufacturing.
Ordered by score. Scores follow the published rules and are not affected by paid placement. Updated 2026-11-13.
Source: FDA Drug Master File list. Holding a DMF is a regulatory filing, not an FDA approval.
Peptide API subsidiary of Aurobindo Pharma with a plant near Hyderabad. Makes generic peptide APIs and runs GMP contract projects from mg to kg scale.
Privately owned Barcelona peptide CDMO founded in 1989, making GMP generic peptide APIs and custom NCE peptides. Holds US DMFs for 10 peptide APIs.
Indian CDMO whose Turbhe, Navi Mumbai site develops and makes peptide APIs by solid- and solution-phase synthesis. Holds US DMFs for 9 peptide APIs.
Swiss peptide and oligonucleotide CDMO with GMP plants in Europe and the US.
Peptide-focused CDMO running GMP manufacturing sites on three continents.
Mumbai peptide API maker acquired by Piramal Pharma in 2021; its oxytocin API is WHO-prequalified; US DMF for oxytocin.
Privately held Hyderabad generics and API group with 36+ plants; US DMFs for semaglutide and vasopressin.
Companies holding active US DMFs for Vasopressin include Auro Peptides Ltd, BCN Peptides SA, Piramal Pharma Ltd (Piramal Pharma Solutions), Bachem Holding AG, PolyPeptide Group, Hemmo Pharmaceuticals Pvt Ltd (Piramal Pharma Solutions) and Hetero Drugs Ltd. Other manufacturers may supply it without a US DMF.
Among listed DMF holders: India (4), Switzerland (2), Spain (1).
No. FDA reviews a DMF when a drug application references it and does not approve DMFs on their own.